Optimisation of follow-up after metabolic surgery

The Lancet Diabetes and Endocrinology

Volumn 6, Issue 6, 2018, Pages 487-499

  Mingrone, Geltrude ^a,b   Bornstein, Stefan ^b,c   Le Roux, Carel W ^d,e  

^a CATHOLIC UNIVERSITY   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

ABDOMINAL PAIN; BODY WEIGHT LOSS; DIET; DIET SUPPLEMENTATION; DISEASE SEVERITY; FOLLOW UP; FRACTURE; GASTRIC BYPASS SURGERY; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; HYPOGLYCEMIA; KWASHIORKOR; MALNUTRITION; MEDICAL ASSESSMENT; METABOLIC SURGERY; MICROELEMENT DEFICIENCY; MINERAL SUPPLEMENTATION; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL DEFICIENCY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVIEW; RISK; RISK ASSESSMENT; RISK REDUCTION; SLEEP DISORDERED BREATHING; SLEEVE GATRECTOMY; SOCIAL PSYCHOLOGY; STOMACH SURGERY; SURGERY; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; AFTERCARE; BARIATRIC SURGERY; DIET THERAPY; OBESITY;

AFTERCARE; BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; HUMANS; NUTRITION THERAPY; OBESITY; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT;

EID: 85041232354     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(17)30434-5     Document Type: Review

References (102)

1. The Look AHEAD Research Group. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 4 (2016), 913–921.
2. Angrisani, L, Santonicola, A, Iovino, P, Formisano, G, Buchwald, H, Scopinaro, N, Bariatric surgery worldwide 2013. Obes Surg 25 (2015), 1822–1832.
3. Angrisani, L, Santonicola, A, Iovino, P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg 27 (2017), 2279–2289.
4. Sjöström, L, Narbro, K, Sjöström, CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007), 741–752.
5. Adams, TD, Gress, RE, Smith, SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357 (2007), 753–761.
6. Sjöström, L, Lindroos, AK, Peltonen, M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004), 2683–2693.
7. Funk, LM, Jolles, S, Fischer, LE, Voils, CI, Patient and referring practitioner characteristics associated with the likelihood of undergoing bariatric surgery: a systematic review. JAMA Surg 150 (2015), 999–1005.
8. Schiavon, CA, Bersch-Ferreria, AC, Santucci, EV, et al. Effects of bariatric surgery in obese patients with hypertension: the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation, 2017 published online Nov 13. DOI:10.1161/CIRCULATIONAHA.117.032130.
9. Chakhtoura, MT, Nakhoul, N, Akl, EA, Mantzoros, CS, El Hajj Fuleihan, GA, Guidelines on vitamin D replacement in bariatric surgery: identification and systematic appraisal. Metabolism 65 (2016), 586–597.
10. Chang, SH, Stoll, CR, Song, J, Varela, JE, Eagon, CJ, Colditz, GA, The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg 149 (2014), 275–287.
11. Eisenberg, D, Azagury, DE, Ghiassi, S, Grover, BT, Kim, JJ, ASMBS position statement on postprandial hyperinsulinemic hypoglycemia after bariatric surgery. Surg Obes Relat Dis 13 (2017), 371–378.
12. Bolckmans, R, Himpens, J, Long-term (>10 yrs) outcome of the laparoscopic biliopancreatic diversion with duodenal switch. Ann Surg 264 (2016), 1029–1037.
13. Rebecchi, F, Allaix, ME, Ugliono, E, Giaccone, C, Toppino, M, Morino, M, Increased esophageal exposure to weakly acidic reflux 5 years after laparoscopic-en-Y gastric bypass. Ann Surg 264 (2016), 871–877.
14. Greenstein, AJ, O'Rourke, RW, Abdominal pain after gastric bypass: suspects and solutions. Am J Surg 201 (2011), 819–827.
15. Schauer, PR, Kashyap, SR, Wolski, K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366 (2012), 1567–1576.
16. Schauer, PR, Bhatt, DL, Kirwan, JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med 370 (2014), 2002–2013.
17. Schauer, PR, Bhatt, DL, Kirwan, JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med 376 (2017), 641–651.
18. Mingrone, G, Panunzi, S, De Gaetano, A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366 (2012), 1577–1585.
19. Mingrone, G, Panunzi, S, De Gaetano, A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386 (2015), 964–973.
20. Ikramuddin, S, Korner, J, Lee, WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 309 (2013), 2240–2249.
21. Ikramuddin, S, Billington, CJ, Lee, W-J, et al. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol 3 (2015), 413–422.
22. Courcoulas, AP, Goodpaster, BH, Eagleton, JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg 149 (2014), 707–715.
23. Suárez Llanos, JP, Fuentes Ferrer, M, Alvarez-Sala-Walther, L, et al. Protein malnutrition incidence comparison after gastric bypass versus biliopancreatic diversion. Nutr Hosp 32 (2015), 80–86.
24. 2 . Obes Surg 25 (2015), 2125–2134.
25. Gletsu-Miller, N, Wright, BN, Mineral malnutrition following bariatric surgery. Adv Nutr 4 (2013), 506–517.
26. Hassn, A, Luhmann, A, Rahmani, S, Morris-Stiff, G, Medium-term results of combined laparoscopic sleeve gastrectomy and modified jejuno-ileal bypass in bariatric surgery. Obes Surg 26 (2016), 2316–2323.
27. Sallé A, Demarsy, D, Poirier, AL, et al. Zinc deficiency: a frequent and underestimated complication after bariatric surgery. Obes Surg 20 (2010), 1660–1670.
28. Livingstone, C, Zinc: physiology, deficiency, and parenteral nutrition. Nutr Clin Pract 30 (2015), 371–382.
29. Muir, A, Hopfer, U, Regional specificity of iron uptake by small intestinal brush-border membranes from normal and iron-deficient mice. Am J Physiol 248 (1985), G376–G379.
30. Ruz, M, Carrasco, F, Rojas, P, et al. Heme- and nonheme-iron absorption and iron status 12 mo after sleeve gastrectomy and Roux-en-Y gastric bypass in morbidly obese women. Am J Clin Nutr 96 (2012), 810–817.
31. Jáuregui-Lobera, I, Iron deficiency and bariatric surgery. Nutrients 5 (2013), 1595–1608.
32. Gloy, VL, Briel, M, Bhatt, DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ, 347, 2013, f5934.
33. Stroh, C, Meyer, F, Manger, T, Beriberi, a severe complication after metabolic surgery—review of the literature. Obes Facts 7 (2014), 246–252.
34. Visentin, M, Diop-Bove, N, Zhao, R, Goldman, ID, The intestinal absorption of folates. Annu Rev Physiol 76 (2014), 251–274.
35. Herzlich, B, Herbert, V, The role of the pancreas in cobalamin (vitamin B12) absorption. Am J Gastroenterol 79 (1984), 489–493.
36. Pelizzo, G, Nakib, G, Alfei, A, et al. Fetal neural tube defects in pregnant women previously submitted to bariatric surgery: more attention to a new emerging entity. Prenat Diagn 33 (2013), 196–197.
37. Eerdekens, A, Debeer, A, Van Hoey, G, et al. Maternal bariatric surgery: adverse outcomes in neonates. Eur J Pediatr 169 (2010), 191–196.
38. Maislos, M, Shany, S, Bile salt deficiency and the absorption of vitamin D metabolites. In vivo study in the rat. Isr J Med Sci 23 (1987), 1114–1117.
39. Pellitero, S, Martínez, E, Puig, R, et al. Evaluation of vitamin and trace element requirements after sleeve gastrectomy at long term. Obes Surg 27 (2017), 1674–1682.
40. Cole, AJ, Beckman, LM, Earthman, CP, Vitamin D status following bariatric surgery: implications and recommendations. Nutr Clin Pract 29 (2014), 751–758.
41. Schafer, AL, Vitamin D and intestinal calcium transport after bariatric surgery. J Steroid Biochem Mol Biol 173 (2017), 202–210.
42. Balsa, JA, Botella-Carretero, JI, Peromingo, R, et al. Chronic increase of bone turnover markers after biliopancreatic diversion is related to secondary hyperparathyroidism and weight loss. Relation with bone mineral density. Obes Surg 20 (2010), 468–473.
43. Jans, G, Matthys, C, Bogaerts, A, et al. Maternal micronutrient deficiencies and related adverse neonatal outcomes after bariatric surgery: a systematic review. Adv Nutr 6 (2015), 420–429.
44. Van Mieghem, T, Van Schoubroeck, D, Depiere, M, Debeer, A, Hanssens, M, Fetal cerebral hemorrhage caused by vitamin K deficiency after complicated bariatric surgery. Obstet Gynecol 112 (2008), 434–436.
45. Shanbhogue, VV, Støving, RK, Frederiksen, KH, et al. Bone structural changes after gastric bypass surgery evaluated by HR-pQCT: a two-year longitudinal study. Eur J Endocrinol 176 (2017), 685–693.
46. Nakamura, KM, Haglind, EG, Clowes, JA, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int 25 (2014), 151–158.
47. Rousseau, C, Jean, S, Gamache, P, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ, 354, 2016, i3794.
48. Lalmohamed, A, de Vries, F, Bazelier, MT, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ, 345, 2012, e5085.
49. van Beek, AP, Emous, M, Laville, M, Tack, J, Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obes Rev 18 (2017), 68–85.
50. Nannipieri, M, Belligoli, A, Guarino, D, et al. Risk factors for spontaneously self-reported postprandial hypoglycemia after bariatric surgery. J Clin Endocrinol Metab 101 (2016), 3600–3607.
51. Roslin, MS, Oren, JH, Polan, BN, Damani, T, Brauner, R, Shah, PC, Abnormal glucose tolerance testing after gastric bypass. Surg Obes Relat Dis 9 (2013), 26–31.
52. Papamargaritis, D, Koukoulis, G, Sioka, E, et al. Dumping symptoms and incidence of hypoglycaemia after provocation test at 6 and 12 months after laparoscopic sleeve gastrectomy. Obes Surg 22 (2012), 1600–1606.
53. Mala, T, Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment. Surg Obes Relat Dis 10 (2014), 1220–1225.
54. Lieske, JC, Mehta, RA, Milliner, DS, Rule, AD, Bergstralh, EJ, Sarr, MG, Kidney stones are common after bariatric surgery. Kidney Int 87 (2015), 839–845.
55. Moreland, AM, Santa Ana, CA, Asplin, JR, et al. Steatorrhea and hyperoxaluria in severely obese patients before and after Roux-en-Y gastric bypass. Gastroenterology 152 (2017), 1055–1067.
56. Thongprayoon, C, Cheungpasitporn, W, Vijayvargiya, P, Anthanont, P, Erickson, SB, The risk of kidney stones following bariatric surgery: a systematic review and meta-analysis. Ren Fail 38 (2016), 424–430.
57. Preiss, K, Brennan, L, Clarke, D, A systematic review of variables associated with the relationship between obesity and depression. Obes Rev 14 (2013), 906–918.
58. Tindle, HA, Omalu, B, Courcoulas, A, Marcus, M, Hammers, J, Kuller, LH, Risk of suicide after long-term follow-up from bariatric surgery. Am J Med 123 (2010), 1036–1042.
59. Dawes, AJ, Maggard-Gibbons, M, Maher, AR, et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA 315 (2016), 150–163.
60. Shekelle, PG, Woolf, SH, Eccles, M, Grimshaw, J, Developing clinical guidelines. West J Med 170 (1999), 348–351.
61. SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis 5 (2009), 387–405.
62. Stegenga, H, Haines, A, Jones, K, Wilding, J, Guideline Development Group. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ, 349, 2014, g6608.
63. Gastrointestinal surgery for severe obesity. Proceedings of a National Institutes of Health consensus development conference. March 25–27, 1991, Bethesda, MD. Am J Clin Nutr 55 (1992), 487S–619S.
64. Ahn, LB, Huang, CS, Forse, RA, Hess, DT, Andrews, C, Farraye, FA, Crohn's disease after gastric bypass surgery for morbid obesity: is there an association?. Inflamm Bowel Dis 11 (2005), 622–624.
65. O'Keefe, KL, Kemmeter, PR, Kemmeter, KD, Bariatric surgery outcomes in patients aged 65 years and older at an American Society for Metabolic and Bariatric Surgery Center of Excellence. Obes Surg 20 (2010), 1199–1205.
66. Opozda, M, Chur-Hansen, A, Wittert, G, Changes in problematic and disordered eating after gastric bypass, adjustable gastric banding and vertical sleeve gastrectomy: a systematic review of pre-post studies. Obes Rev 17 (2016), 770–792.
67. Bingham, NC, Rose, SR, Inge, TH, Bariatric surgery in hypothalamic obesity. Front Endocrinol (Lausanne), 3, 2012, 23.
68. Katz, PO, Gerson, LB, Vela, MF, Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 108 (2013), 308–328.
69. Eslick, GD, Lim, LL, Byles, JE, Xia, HH, Talley, NJ, Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94 (1999), 2373–2379.
70. Fleisher, LA, Beckman, JA, Brown, KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 116 (2007), e418–e499.
71. Devereaux, PJ, Goldman, L, Cook, DJ, Gilbert, K, Leslie, K, Guyatt, GH, Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 173 (2005), 627–634.
72. Eagle, KA, Berger, PB, Calkins, H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 39 (2002), 542–553.
73. Redline, S, Baker-Goodwin, S, Bakker, JP, et al. Patient partnerships transforming sleep medicine research and clinical care: perspectives from the Sleep Apnea Patient-Centered Outcomes Network. J Clin Sleep Med 12 (2016), 1053–1058.
74. Jonas, DE, Amick, HR, Feltner, C, et al. Screening for obstructive sleep apnea in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA 317 (2017), 415–433.
75. Redline, S, Screening for obstructive sleep apnea. Implications for the sleep health of the population. JAMA 317 (2017), 368–370.
76. de Raaff, CAL, Gorter-Stam, MAW, de Vries, N, et al. Perioperative management of obstructive sleep apnea in bariatric surgery: a consensus guideline. Surg Obes Relat Dis 13 (2017), 1095–1109.
77. Kapur, VK, Auckley, DH, Chowdhuri, S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 13 (2017), 479–504.
78. Centers for Medicare & Medicaid Services. Decision memo for sleep testing for obstructive sleep apnea (OSA) (CAG-00405N). Baltimore, MD: US Centers for Medicare & Medicaid services. https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=227&ver=11&NcaName=Sleep+Testing+for+Obstructive+Sleep+Apnea+(OSA)&CoverageSelection=National&KeyWord=sleep+testing&KeyWordLookUp=Title&KeyWordSearchType=And&bc=gAAAACAAEAAA& (accessed Dec 8, 2017).
79. DeFronzo, RA, Tripathy, D, Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32:suppl 2 (2009), S157–S163.
80. Inzucchi, SE, Bergenstal, RM, Buse, JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 58 (2015), 429–442.
81. Garber, AJ, Abrahamson, MJ, Barzilay, JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2017 executive summary. Endocr Pract 23 (2017), 207–238.
82. Fox, CS, Golden, SH, Anderson, C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 38 (2015), 1777–1803.
83. Watanabe, A, Seki, Y, Haruta, H, Kikkawa, E, Kasama, K, Preoperative weight loss and operative outcome after laparoscopic sleeve gastrectomy. Obes Surg 27 (2017), 2515–2521.
84. Gerber, P, Anderin, C, Gustafsson, UO, Thorell, A, Weight loss before gastric bypass and postoperative weight change: data from the Scandinavian Obesity Registry (SOReg). Surg Obes Relat Dis 12 (2016), 556–562.
85. Van Nieuwenhove, Y, Dambrauskas, Z, Campillo-Soto, A, et al. Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study. Arch Surg 146 (2011), 1300–1305.
86. American Diabetes Association. 13. Diabetes care in the hospital. Diabetes Care 39:suppl 1 (2016), S99–S104.
87. Rubino, F, Nathan, DM, Eckel, RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 39 (2016), 861–877.
88. Trumbo, P, Schlicker, S, Yates, AA, Poos, M Food and Nutrition Board of the Institute of Medicine, The National Academies. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc 102 (2002), 1621–1630.
89. Busetto, L, Dicker, D, Azran, C, et al. Practical recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management. Obes Facts 10 (2017), 597–632.
90. Mechanick, JI, Youdim, A, Jones, DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) 21:suppl 1 (2013), S1–S27.
91. Switzer, NJ, Marcil, G, Prasad, S, et al. Long-term hypovitaminosis D and secondary hyperparathyroidism outcomes of the Roux-en-Y gastric bypass: a systematic review. Obes Rev 18 (2017), 560–566.
92. Peterson, LA, Zeng, X, Caufield-Noll, CP, Schweitzer, MA, Magnuson, TH, Steele, KE, Vitamin D status and supplementation before and after bariatric surgery: a comprehensive literature review. Surg Obes Relat Dis 12 (2016), 693–702.
93. Dilektasli, E, Erol, MF, Cayci, HM, et al. Low educational status and childhood obesity associated with insufficient mid-term weight loss after sleeve gastrectomy: a retrospective observational cohort study. Obes Surg 27 (2017), 162–168.
94. de Raaff, CA, Coblijn, UK, de Vries, N, et al. Predictive factors for insufficient weight loss after bariatric surgery: does obstructive sleep apnea influence weight loss?. Obes Surg 26 (2016), 1048–1056.
95. Sheppard, CE, Lester, EL, Chuck, AW, Birch, DW, Karmali, S, de Gara, CJ, The economic impact of weight regain. Gastroenterol Res Pract, 2013, 2013, 379564.
96. Brethauer, SA, Nfonsam, V, Sherman, V, Udomsawaengsup, S, Schauer, PR, Chand, B, Endoscopy and upper gastrointestinal contrast studies are complementary in evaluation of weight regain after bariatric surgery. Surg Obes Relat Dis 2 (2006), 643–648.
97. Heneghan, HM, Yimcharoen, P, Brethauer, SA, Kroh, M, Chand, B, Influence of pouch and stoma size on weight loss after gastric bypass. Surg Obes Relat Dis 8 (2012), 408–415.
98. Gallo, AS, DuCoin, CG, Berducci, MA, et al. Endoscopic revision of gastric bypass: holy grail or epic fail?. Surg Endosc 30 (2016), 3922–3927.
99. Stanford, FC, Alfaris, N, Gomez, G, et al. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: a multi-center study. Surg Obes Relat Dis 13 (2017), 491–500.
100. Le Roux, CW, Astrup, A, Fujioka, K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet 389 (2017), 1399–1409.
101. Topart, PA, Becouarn, G, Revision and reversal after biliopancreatic diversion for excessive side effects or ineffective weight loss: a review of the current literature on indications and procedures. Surg Obes Relat Dis 11 (2015), 965–972.
102. Shoar, S, Nguyen, T, Ona, MA, et al. Roux-en-Y gastric bypass reversal: a systematic review. Surg Obes Relat Dis 12 (2016), 1366–1372.